DCM Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,571
Closed -$326K 208
2022
Q2
$326K Sell
5,571
-7,000
-56% -$386K 0.14% 141
2022
Q1
$666K Buy
12,571
+2,281
+22% +$132K 0.24% 106
2021
Q4
$624K Buy
10,290
+3,732
+57% +$222K 0.18% 123
2021
Q3
$368K Buy
+6,558
New +$360K 0.14% 166

Other funds holding PBH

DCM Advisors's PBH Position: Q3 2022 in Review

DCM Advisors sold out of Prestige Consumer Healthcare (PBH) in Q3 2022, closing a stake of 5,571 shares — an estimated $326K sold.

DCM Advisors first reported a position in PBH in Q3 2021 and held it in 4 quarters. The position peaked at $666K in Q1 2022. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2022.

  • DCM Advisors reported no remaining Prestige Consumer Healthcare position as of Q3 2022 after selling out during the quarter.
  • DCM Advisors sold 5,571 Prestige Consumer Healthcare shares in Q3 2022, an estimated $326K.
  • DCM Advisors first reported a position in Prestige Consumer Healthcare in Q3 2021 and held it in 4 quarters.
  • DCM Advisors's Prestige Consumer Healthcare position peaked at $666K in Q1 2022.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2022.

Based on DCM Advisors's 13F filing for Q3 2022, filed 11 Sep 2023.